Colorectal Neoplasm

Oncology
7
Pipeline Programs
6
Companies
50
Clinical Trials
1 recruiting
1
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
1
3
0
0
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
150%
Monoclonal Antibody
150%
+ 5 programs with unclassified modality

On Market (1)

Approved therapies currently available

Sanofi
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINERApproved
milrinone lactate
Sanofi
injection1994

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Sanofi
SanofiPARIS, France
1 program
1
1
PRIMACOR IN DEXTROSE 5% IN PLASTIC CONTAINER(OS)Phase 25 trials
Active Trials
NCT00043706CompletedEst. Sep 2003
NCT01239017Withdrawn0
NCT06694025Not Yet Recruiting670Est. Jan 2028
+2 more trials
DS
Daiichi SankyoChina - Shanghai
2 programs
1
1
DS-8201aPhase 21 trial
DS-8273a + nivolumabPhase 1Monoclonal Antibody1 trial
Active Trials
NCT02991196Terminated4Est. Sep 2017
NCT03384940Completed86Est. Nov 2020
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
DS-8201aPhase 2
Transgene
TransgeneFrance - Illkirch-Graffenstaden
1 program
1
TG6002Phase 1/21 trial
Active Trials
NCT03724071TerminatedEst. Feb 2023
Karyopharm Therapeutics
1 program
1
SelinexorPhase 11 trial
Active Trials
NCT02384850TerminatedEst. Mar 2017
Bayer
BayerLEVERKUSEN, Germany
1 program
RegorafenibN/ASmall Molecule1 trial
Active Trials
NCT01959269Completed483Est. Jul 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
SanofiOS
SanofiOS
SanofiOS
SanofiOS
SanofiOS
SanofiOS
SanofiOS
SanofiOS
SanofiOS
SanofiOS
SanofiOS
SanofiOS
SanofiOS
SanofiOS
SanofiOS

Showing 15 of 50 trials with date data

Clinical Trials (50)

Total enrollment: 14,597 patients across 50 trials

Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above

Start: Jun 2025Est. completion: Dec 2025203 patients
Phase 4Completed

Glucose Consumption in MS Using [F-18]FDG-PET

Start: May 2025Est. completion: Dec 202750 patients
Phase 4Recruiting

A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme

Start: Nov 2023Est. completion: Oct 20248 patients
Phase 4Completed

Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation

Start: Oct 2021Est. completion: Jun 2024339 patients
Phase 4Completed

China Post-marketing Surveillance (PMS) Study of Aldurazyme®

Start: Oct 2021Est. completion: Jul 202312 patients
Phase 4Completed

China Post-marketing Surveillance (PMS) Study of Fabrazyme®

Start: Oct 2021Est. completion: Mar 202322 patients
Phase 4Completed

Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence

Start: May 2021Est. completion: Dec 202222 patients
Phase 4Terminated

Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa

Start: Jan 2021Est. completion: Jan 2023273 patients
Phase 4Completed

MRI Assessment of Mode of Action of Bisacodyl, Multiple Doses

Start: Oct 2020Est. completion: Nov 202212 patients
Phase 4Completed

MRI Assessment of Mode of Action of Bisacodyl, Single Dose

Start: Sep 2020Est. completion: Nov 202212 patients
Phase 4Completed

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Start: Sep 2020Est. completion: Dec 202090 patients
Phase 4Completed

To Assess the Glycosphingolipid Clearance and Clinical Effects of Switching to Agalsidase Beta (Fabrazyme) Versus Continuing on Agalsidase Alfa (Replagal) in Male Patients With Classic Fabry Disease

Start: Sep 2020Est. completion: Nov 20230
Phase 4Withdrawn

Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 Weeks

Start: May 2020Est. completion: Jul 202182 patients
Phase 4Completed

Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive

Start: Jun 2019Est. completion: Dec 20201,293 patients
Phase 4Completed

To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis

Start: Mar 2019Est. completion: May 2022121 patients
Phase 4Completed

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines

Start: Sep 2017Est. completion: Nov 2017240 patients
Phase 4Completed

Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis

Start: Oct 2016Est. completion: Aug 20212,571 patients
Phase 4Completed

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations

Start: Sep 2016Est. completion: Dec 2016180 patients
Phase 4Completed

Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea

Start: Jul 2016Est. completion: Jun 20191,311 patients
Phase 4Completed

Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier

Start: Dec 2015Est. completion: Mar 2016110 patients
Phase 4Completed

Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects

Start: Oct 2015Est. completion: Mar 201660 patients
Phase 4Completed

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

Start: Sep 2015Est. completion: Jul 2016208 patients
Phase 4Completed

Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses

Start: Aug 2015Est. completion: Dec 2016240 patients
Phase 4Completed

Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia

Start: Apr 2015Est. completion: Feb 2023161 patients
Phase 4Terminated

Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, China

Start: Sep 2014Est. completion: Oct 2015602 patients
Phase 4Completed

Evaluation of Efficacy of Dellegra in Exposure Unit

Start: Jun 2014Est. completion: Jun 201424 patients
Phase 4Completed

A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines

Start: Mar 2014Est. completion: Aug 2015336 patients
Phase 4Completed

Lixisenatide-The Effects on Glucose and Lipid Metabolism in Type 2 Diabetes

Start: Jan 2014Est. completion: Jan 20168 patients
Phase 4Completed

Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents

Start: Dec 2013Est. completion: Aug 2015355 patients
Phase 4Completed

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults

Start: Sep 2013Est. completion: Jul 2014208 patients
Phase 4Completed

Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

Start: Aug 2013Est. completion: Mar 2017171 patients
Phase 4Completed

Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients

Start: Jun 2013Est. completion: Nov 20151,001 patients
Phase 4Completed

A Trial Investigating the Accuracy and Precision of the BGStar® and iBGStar® Blood Glucose Meter in Subjects With Type 1 Diabetes

Start: Nov 201220 patients
Phase 4Completed

Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.

Start: Sep 2012Est. completion: Feb 2013200 patients
Phase 4Completed

Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents

Start: Jun 2012Est. completion: Jun 2013423 patients
Phase 4Completed

Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy

Start: May 2012Est. completion: Jan 201411 patients
Phase 4Terminated

A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase Beta

Start: Apr 2012Est. completion: Mar 201315 patients
Phase 4Completed

A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s)

Start: Mar 2012Est. completion: Sep 2013237 patients
Phase 4Completed

Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China

Start: Dec 2011Est. completion: Dec 2012900 patients
Phase 4Completed

Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting

Start: Nov 2011Est. completion: Jun 2014205 patients
Phase 4Completed

Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients

Start: Sep 2011Est. completion: Jul 2013300 patients
Phase 4Unknown

Regulatory Post-Marketing Surveillance Study for TETRAXIM™

Start: Jun 2011Est. completion: Nov 2015600 patients
Phase 4Completed

Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4

Start: Jan 2011Est. completion: Mar 201630 patients
Phase 4Terminated

A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants

Start: Oct 2010Est. completion: Dec 20222 patients
Phase 4Terminated

Post Marketing Surveillance for ADACEL™ in South Korea

Start: Jun 2010Est. completion: Sep 2016659 patients
Phase 4Completed

Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat Treatment

Start: Feb 2010Est. completion: Sep 2011394 patients
Phase 4Completed

Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects

Start: Oct 2008Est. completion: Dec 2016220 patients
Phase 4Completed

Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients

Start: Sep 2008Est. completion: Jul 201011 patients
Phase 4Completed

Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®

Start: Sep 2008Est. completion: Jan 200932 patients
Phase 4Completed

Bone Microarchitecture in Osteopenic Postmenopausal Women

Start: Jul 2008Est. completion: Feb 200913 patients
Phase 4Terminated

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 14,597 patients
6 companies competing in this space